MaxCyte Company > Press Releases
2013
May 20, 2013 (PDF)
MaxCyte Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation
MaxCyte Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation
April 29, 2013 (PDF)
MaxCyte Presents Unprecedented CHO-Based Transient Gene Expression Data for Gram Scale Antibody Production and Rapid Stable Cell Line Generation at CHI's 2013 Protein and Antibody Engineering Summit (PEGS).
MaxCyte Presents Unprecedented CHO-Based Transient Gene Expression Data for Gram Scale Antibody Production and Rapid Stable Cell Line Generation at CHI's 2013 Protein and Antibody Engineering Summit (PEGS).
April 23, 2013 (PDF)
MaxCyte Highlights the Use of Large Scale Transient Transfection for High Throughput Screening in Biologically Relevant Cells in an Upcoming Educational Webinar Presentation
MaxCyte Highlights the Use of Large Scale Transient Transfection for High Throughput Screening in Biologically Relevant Cells in an Upcoming Educational Webinar Presentation
March 27, 2013 (PDF)
MEDINET and MaxCyte announce publication of joint collaboration supporting delivery of enhanced potency immunotherapy technology for treatment of cancer
MEDINET and MaxCyte announce publication of joint collaboration supporting delivery of enhanced potency immunotherapy technology for treatment of cancer
February 8, 2013 (PDF)
MaxCyte Presents High Performance, CHO-Based Transgene Expression for Gram Scale Antibody Production Using Flow Electroporation at Informa's 2013 Cell Line Development and Engineering Conference
MaxCyte Presents High Performance, CHO-Based Transgene Expression for Gram Scale Antibody Production Using Flow Electroporation at Informa's 2013 Cell Line Development and Engineering Conference
January 21, 2013 (PDF)
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transient Transfection for Streamlining Antibody Development and Production at PepTalk 2013, Booth #307
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transient Transfection for Streamlining Antibody Development and Production at PepTalk 2013, Booth #307
January 11, 2013 (PDF)
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transfection for Cell‐Based Assays at the SLAS2013 Conference and Exhibition in Orlando, Booth #428
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transfection for Cell‐Based Assays at the SLAS2013 Conference and Exhibition in Orlando, Booth #428
2012
December 11, 2012 (PDF)
MaxCyte Highlights High Titer Protein Production Using Biologically Relevant Cells in an Upcoming Educational Webinar Presentation
MaxCyte Highlights High Titer Protein Production Using Biologically Relevant Cells in an Upcoming Educational Webinar Presentation
March 20, 2012 (PDF)
MaxCyte Highlights Gram Scale Protein Production Capability using CHO Transient Transfection in an Upcoming Educational Webinar Presentation
MaxCyte Highlights Gram Scale Protein Production Capability using CHO Transient Transfection in an Upcoming Educational Webinar Presentation
February 13, 2012 (PDF)
MaxCyte Highlights Gram‐Scale Antibody & Protein Production from Transient Transfection of CHO Cells and MaxCyte® VLX™ Large Scale Transfection System Launch
MaxCyte Highlights Gram‐Scale Antibody & Protein Production from Transient Transfection of CHO Cells and MaxCyte® VLX™ Large Scale Transfection System Launch
February 6, 2012 (PDF)
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transfection for Cell‐Based Assays & Protein Production at the SLAS2012 Conference and Exhibition in San Diego, Booth #848
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transfection for Cell‐Based Assays & Protein Production at the SLAS2012 Conference and Exhibition in San Diego, Booth #848
January 9, 2012 (PDF)
The MaxCyte VLX Large Scale Transfection System for Protein and Antibody Production is Launched at PepTalk 2012
The MaxCyte VLX Large Scale Transfection System for Protein and Antibody Production is Launched at PepTalk 2012
2011
March 28, 2011 (PDF)
MaxCyte Highlights Innovations in Scalable, High-Throughput Transfection for Cell-Based Assays & Protein Production at the SBS Annual Meeting in Orlando, FL, Booth #812
MaxCyte Highlights Innovations in Scalable, High-Throughput Transfection for Cell-Based Assays & Protein Production at the SBS Annual Meeting in Orlando, FL, Booth #812
January 31, 2011 (PDF)
he MaxCyte® STX™ Scalable Transfection System Demonstrated to Improve Drug Discovery Screening at the LabAutomation 2011 Conference in Palm Springs, CA, Booth #590
he MaxCyte® STX™ Scalable Transfection System Demonstrated to Improve Drug Discovery Screening at the LabAutomation 2011 Conference in Palm Springs, CA, Booth #590
2010
September 22, 2010 (PDF)
MaxCyte Demonstrates How to Develop and Optimize Scalable Cell Based Assays at the MipTec 2010 Conference in Basel, Stand G16
MaxCyte Demonstrates How to Develop and Optimize Scalable Cell Based Assays at the MipTec 2010 Conference in Basel, Stand G16
May 12, 2010 (PDF)
CCS Cell Culture Service GmbH Acquires the MaxCyte® STX™ Scalable Transfection System for Cell Line Development
CCS Cell Culture Service GmbH Acquires the MaxCyte® STX™ Scalable Transfection System for Cell Line Development
April 13, 2010 (PDF)
MaxCyte STXpert Users Explain How to Fast Track Cell Based Assay Development at the SBS Annual Meeting in Phoenix, Booth 342
MaxCyte STXpert Users Explain How to Fast Track Cell Based Assay Development at the SBS Annual Meeting in Phoenix, Booth 342
January 26, 2010 (PDF)
Improved Optimization and Development of Ion Channels for Cell-Based Assays MaxCyte Webinar with Case Studies from BioFocus
Improved Optimization and Development of Ion Channels for Cell-Based Assays MaxCyte Webinar with Case Studies from BioFocus
2009
June 16, 2009 (PDF)
MaxCyte Webinar with Case Studies from ChanTest Corporation: Improving Large Scale GPCR and Ion Channel Assays
MaxCyte Webinar with Case Studies from ChanTest Corporation: Improving Large Scale GPCR and Ion Channel Assays
May 4, 2009 (PDF)
MaxCyte to Present on Development of Novel Tumor-Targeted Enhanced Potency T Cell Immunotherapy at The 15th Annual Meeting of the International Society of Cellular Therapy (ISCT)
MaxCyte to Present on Development of Novel Tumor-Targeted Enhanced Potency T Cell Immunotherapy at The 15th Annual Meeting of the International Society of Cellular Therapy (ISCT)
April 30, 2009 (PDF)
MaxCyte GT Flow Transfection System Now available to Academic and Clinical Investigators
MaxCyte GT Flow Transfection System Now available to Academic and Clinical Investigators
April 27, 2009 (PDF)
MaxCyte STX Scalable Transfection System for Cell Based Assays in Drug Discovery: Screening Data to be Presented at the 15th Annual SBS Meeting in Lille, France
MaxCyte STX Scalable Transfection System for Cell Based Assays in Drug Discovery: Screening Data to be Presented at the 15th Annual SBS Meeting in Lille, France
February 27, 2009 (PDF)
MaxCyte Presents Membrane Protein Expression Data at the Biophysical Society's Ion Channel Meeting
MaxCyte Presents Membrane Protein Expression Data at the Biophysical Society's Ion Channel Meeting
February 17, 2009 (PDF)
MaxCyte Introduces the GT™ Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
MaxCyte Introduces the GT™ Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
January 26, 2009 (PDF)
The MaxCyte® STX™ Scalable Transfection System to be Presented at the Rapid Fire Innovation Session at LabAutomation2009
The MaxCyte® STX™ Scalable Transfection System to be Presented at the Rapid Fire Innovation Session at LabAutomation2009
2008
December 15, 2008 (PDF)
MaxCyte Presents a Panel Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery – LIVE Q&A to Follow
MaxCyte Presents a Panel Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery – LIVE Q&A to Follow
December 4, 2008 (PDF)
MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
November 18, 2008 (PDF)
MaxCyte STX ® Scalable Transfection System Launched in Europe at SMi's Cell-Based Assays Conference in London
MaxCyte STX ® Scalable Transfection System Launched in Europe at SMi's Cell-Based Assays Conference in London
November 12, 2008 (PDF)
MaxCyte Hosts LIVE Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
MaxCyte Hosts LIVE Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
October 22, 2008 (PDF)
The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
October 3, 2008 (PDF)
MaxCyte to Present at AABB Annual Meeting & TXPO 2008 in Montréal, Québec, Canada
MaxCyte to Present at AABB Annual Meeting & TXPO 2008 in Montréal, Québec, Canada
October 2, 2008 (PDF)
MaxCyte and Medinet to Present at The 10th International Symposium on Dendritic Cells in Kobe, Japan
MaxCyte and Medinet to Present at The 10th International Symposium on Dendritic Cells in Kobe, Japan
September 24, 2008 (PDF)
MaxCyte Debuts the STX Scalable Transfection System at the ACT Assays & Cellular Targets Meeting
MaxCyte Debuts the STX Scalable Transfection System at the ACT Assays & Cellular Targets Meeting
August 20, 2008 (PDF)
Medinet Starts Commercialization of Novel Cancer Immunotherapy Technology in Japan Utilizing Maxcyte's Cell Loading System
Medinet Starts Commercialization of Novel Cancer Immunotherapy Technology in Japan Utilizing Maxcyte's Cell Loading System
June 16, 2008 (PDF)
MaxCyte to Present at 2008 BIO International Convention
MaxCyte to Present at 2008 BIO International Convention
April 21, 2008 (PDF)
Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
April 7, 2008 (PDF)
MaxCyte to Present at BIO-Europe Spring 2008 Conference
MaxCyte to Present at BIO-Europe Spring 2008 Conference
February 26, 2008 (PDF)
MaxCyte to Present at the 3rd Annual Stem Cell Summit
MaxCyte to Present at the 3rd Annual Stem Cell Summit
February 6, 2008 (PDF)
MaxCyte to Present at the BIO CEO & Investor Conference
MaxCyte to Present at the BIO CEO & Investor Conference
January 28, 2008 (PDF)
MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008
MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008